nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCB1—melanoma	0.175	1	CbGaD
Carbamazepine—CYP1A2—Carmustine—melanoma	0.0751	0.155	CbGbCtD
Carbamazepine—CYP1A2—Vemurafenib—melanoma	0.0594	0.122	CbGbCtD
Carbamazepine—CYP3A4—Temozolomide—melanoma	0.0568	0.117	CbGbCtD
Carbamazepine—ABCC2—Docetaxel—melanoma	0.0547	0.112	CbGbCtD
Carbamazepine—CYP1A2—Dacarbazine—melanoma	0.0455	0.0937	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0365	0.0751	CbGbCtD
Carbamazepine—CYP3A7—Docetaxel—melanoma	0.0365	0.0751	CbGbCtD
Carbamazepine—ABCB1—Dactinomycin—melanoma	0.0345	0.071	CbGbCtD
Carbamazepine—CYP3A4—Vemurafenib—melanoma	0.0311	0.064	CbGbCtD
Carbamazepine—CYP3A5—Docetaxel—melanoma	0.0274	0.0563	CbGbCtD
Carbamazepine—ABCB1—Docetaxel—melanoma	0.0178	0.0367	CbGbCtD
Carbamazepine—CYP3A4—Docetaxel—melanoma	0.0107	0.022	CbGbCtD
Carbamazepine—Nepafenac—PTGS2—melanoma	0.000363	0.127	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—melanoma	0.000355	0.124	CrCbGaD
Carbamazepine—Erythema multiforme—Temozolomide—melanoma	0.000352	0.0018	CcSEcCtD
Carbamazepine—Eye disorder—Temozolomide—melanoma	0.000348	0.00178	CcSEcCtD
Carbamazepine—Tinnitus—Temozolomide—melanoma	0.000347	0.00178	CcSEcCtD
Carbamazepine—Cardiac disorder—Temozolomide—melanoma	0.000346	0.00177	CcSEcCtD
Carbamazepine—Flushing—Temozolomide—melanoma	0.000346	0.00177	CcSEcCtD
Carbamazepine—Arrhythmia—Carmustine—melanoma	0.000344	0.00176	CcSEcCtD
Carbamazepine—Leukopenia—Bleomycin—melanoma	0.000344	0.00176	CcSEcCtD
Carbamazepine—Dizziness—Vemurafenib—melanoma	0.000342	0.00175	CcSEcCtD
Carbamazepine—Alopecia—Carmustine—melanoma	0.00034	0.00174	CcSEcCtD
Carbamazepine—Angiopathy—Temozolomide—melanoma	0.000338	0.00173	CcSEcCtD
Carbamazepine—Mental disorder—Carmustine—melanoma	0.000338	0.00173	CcSEcCtD
Carbamazepine—Ataxia—Docetaxel—melanoma	0.000337	0.00172	CcSEcCtD
Carbamazepine—Immune system disorder—Temozolomide—melanoma	0.000336	0.00172	CcSEcCtD
Carbamazepine—Mediastinal disorder—Temozolomide—melanoma	0.000336	0.00172	CcSEcCtD
Carbamazepine—Malnutrition—Carmustine—melanoma	0.000335	0.00172	CcSEcCtD
Carbamazepine—Erythema—Carmustine—melanoma	0.000335	0.00172	CcSEcCtD
Carbamazepine—Chills—Temozolomide—melanoma	0.000334	0.00171	CcSEcCtD
Carbamazepine—Anaemia—Dactinomycin—melanoma	0.000331	0.0017	CcSEcCtD
Carbamazepine—Liver function test abnormal—Docetaxel—melanoma	0.00033	0.00169	CcSEcCtD
Carbamazepine—Vomiting—Vemurafenib—melanoma	0.000329	0.00169	CcSEcCtD
Carbamazepine—Alopecia—Temozolomide—melanoma	0.000329	0.00169	CcSEcCtD
Carbamazepine—Myalgia—Bleomycin—melanoma	0.000327	0.00168	CcSEcCtD
Carbamazepine—Chest pain—Bleomycin—melanoma	0.000327	0.00168	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Docetaxel—melanoma	0.000327	0.00167	CcSEcCtD
Carbamazepine—Rash—Vemurafenib—melanoma	0.000326	0.00167	CcSEcCtD
Carbamazepine—Mental disorder—Temozolomide—melanoma	0.000326	0.00167	CcSEcCtD
Carbamazepine—Dermatitis—Vemurafenib—melanoma	0.000326	0.00167	CcSEcCtD
Carbamazepine—Back pain—Carmustine—melanoma	0.000324	0.00166	CcSEcCtD
Carbamazepine—Headache—Vemurafenib—melanoma	0.000324	0.00166	CcSEcCtD
Carbamazepine—Malnutrition—Temozolomide—melanoma	0.000324	0.00166	CcSEcCtD
Carbamazepine—Erythema—Temozolomide—melanoma	0.000324	0.00166	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000322	0.00165	CcSEcCtD
Carbamazepine—Cramp muscle—Docetaxel—melanoma	0.000322	0.00165	CcSEcCtD
Carbamazepine—Leukopenia—Dactinomycin—melanoma	0.000321	0.00164	CcSEcCtD
Carbamazepine—Dysgeusia—Temozolomide—melanoma	0.000317	0.00163	CcSEcCtD
Carbamazepine—Magnesium salicylate—ALB—melanoma	0.000316	0.111	CrCbGaD
Carbamazepine—Confusional state—Bleomycin—melanoma	0.000316	0.00162	CcSEcCtD
Carbamazepine—Vision blurred—Carmustine—melanoma	0.000316	0.00162	CcSEcCtD
Carbamazepine—Tremor—Carmustine—melanoma	0.000314	0.00161	CcSEcCtD
Carbamazepine—Anaphylactic shock—Bleomycin—melanoma	0.000314	0.00161	CcSEcCtD
Carbamazepine—Oedema—Bleomycin—melanoma	0.000314	0.00161	CcSEcCtD
Carbamazepine—Back pain—Temozolomide—melanoma	0.000313	0.00161	CcSEcCtD
Carbamazepine—Infection—Bleomycin—melanoma	0.000312	0.0016	CcSEcCtD
Carbamazepine—Anaemia—Carmustine—melanoma	0.00031	0.00159	CcSEcCtD
Carbamazepine—Dysphagia—Docetaxel—melanoma	0.000309	0.00158	CcSEcCtD
Carbamazepine—Agitation—Carmustine—melanoma	0.000308	0.00158	CcSEcCtD
Carbamazepine—Nausea—Vemurafenib—melanoma	0.000307	0.00157	CcSEcCtD
Carbamazepine—Thrombocytopenia—Bleomycin—melanoma	0.000307	0.00157	CcSEcCtD
Carbamazepine—Vision blurred—Temozolomide—melanoma	0.000305	0.00156	CcSEcCtD
Carbamazepine—Myalgia—Dactinomycin—melanoma	0.000305	0.00156	CcSEcCtD
Carbamazepine—Tremor—Temozolomide—melanoma	0.000304	0.00156	CcSEcCtD
Carbamazepine—Salsalate—PTGS2—melanoma	0.000302	0.106	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—melanoma	0.000302	0.106	CrCbGaD
Carbamazepine—Leukopenia—Carmustine—melanoma	0.0003	0.00154	CcSEcCtD
Carbamazepine—Anaemia—Temozolomide—melanoma	0.0003	0.00153	CcSEcCtD
Carbamazepine—Anorexia—Bleomycin—melanoma	0.000299	0.00153	CcSEcCtD
Carbamazepine—Agitation—Temozolomide—melanoma	0.000298	0.00153	CcSEcCtD
Carbamazepine—Angioedema—Temozolomide—melanoma	0.000296	0.00152	CcSEcCtD
Carbamazepine—Pancytopenia—Docetaxel—melanoma	0.000294	0.0015	CcSEcCtD
Carbamazepine—Hypotension—Bleomycin—melanoma	0.000293	0.0015	CcSEcCtD
Carbamazepine—Oedema—Dactinomycin—melanoma	0.000292	0.0015	CcSEcCtD
Carbamazepine—Vertigo—Temozolomide—melanoma	0.000291	0.00149	CcSEcCtD
Carbamazepine—Convulsion—Carmustine—melanoma	0.000291	0.00149	CcSEcCtD
Carbamazepine—Infection—Dactinomycin—melanoma	0.000291	0.00149	CcSEcCtD
Carbamazepine—Leukopenia—Temozolomide—melanoma	0.00029	0.00149	CcSEcCtD
Carbamazepine—Hypertension—Carmustine—melanoma	0.00029	0.00148	CcSEcCtD
Carbamazepine—Thrombocytopenia—Dactinomycin—melanoma	0.000286	0.00147	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000286	0.00146	CcSEcCtD
Carbamazepine—Myalgia—Carmustine—melanoma	0.000286	0.00146	CcSEcCtD
Carbamazepine—Chest pain—Carmustine—melanoma	0.000286	0.00146	CcSEcCtD
Carbamazepine—Anxiety—Carmustine—melanoma	0.000285	0.00146	CcSEcCtD
Carbamazepine—Paraesthesia—Bleomycin—melanoma	0.000282	0.00144	CcSEcCtD
Carbamazepine—Weight increased—Docetaxel—melanoma	0.000281	0.00144	CcSEcCtD
Carbamazepine—Convulsion—Temozolomide—melanoma	0.000281	0.00144	CcSEcCtD
Carbamazepine—Hypertension—Temozolomide—melanoma	0.00028	0.00143	CcSEcCtD
Carbamazepine—Dyspnoea—Bleomycin—melanoma	0.00028	0.00143	CcSEcCtD
Carbamazepine—Anorexia—Dactinomycin—melanoma	0.000279	0.00143	CcSEcCtD
Carbamazepine—Pneumonia—Docetaxel—melanoma	0.000277	0.00142	CcSEcCtD
Carbamazepine—Confusional state—Carmustine—melanoma	0.000276	0.00141	CcSEcCtD
Carbamazepine—Arthralgia—Temozolomide—melanoma	0.000276	0.00141	CcSEcCtD
Carbamazepine—Myalgia—Temozolomide—melanoma	0.000276	0.00141	CcSEcCtD
Carbamazepine—Infestation NOS—Docetaxel—melanoma	0.000276	0.00141	CcSEcCtD
Carbamazepine—Infestation—Docetaxel—melanoma	0.000276	0.00141	CcSEcCtD
Carbamazepine—Anxiety—Temozolomide—melanoma	0.000275	0.00141	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000274	0.0014	CcSEcCtD
Carbamazepine—Oedema—Carmustine—melanoma	0.000274	0.0014	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000273	0.0014	CcSEcCtD
Carbamazepine—Decreased appetite—Bleomycin—melanoma	0.000273	0.0014	CcSEcCtD
Carbamazepine—Infection—Carmustine—melanoma	0.000272	0.00139	CcSEcCtD
Carbamazepine—Renal failure—Docetaxel—melanoma	0.000271	0.00139	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Docetaxel—melanoma	0.00027	0.00138	CcSEcCtD
Carbamazepine—Dry mouth—Temozolomide—melanoma	0.00027	0.00138	CcSEcCtD
Carbamazepine—Jaundice—Docetaxel—melanoma	0.000269	0.00138	CcSEcCtD
Carbamazepine—Stomatitis—Docetaxel—melanoma	0.000269	0.00138	CcSEcCtD
Carbamazepine—Pain—Bleomycin—melanoma	0.000268	0.00137	CcSEcCtD
Carbamazepine—Conjunctivitis—Docetaxel—melanoma	0.000268	0.00137	CcSEcCtD
Carbamazepine—Thrombocytopenia—Carmustine—melanoma	0.000268	0.00137	CcSEcCtD
Carbamazepine—Tachycardia—Carmustine—melanoma	0.000267	0.00137	CcSEcCtD
Carbamazepine—Confusional state—Temozolomide—melanoma	0.000267	0.00137	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000266	0.00136	CcSEcCtD
Carbamazepine—Oedema—Temozolomide—melanoma	0.000264	0.00135	CcSEcCtD
Carbamazepine—Anaphylactic shock—Temozolomide—melanoma	0.000264	0.00135	CcSEcCtD
Carbamazepine—Infection—Temozolomide—melanoma	0.000263	0.00135	CcSEcCtD
Carbamazepine—Anorexia—Carmustine—melanoma	0.000261	0.00134	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Docetaxel—melanoma	0.000261	0.00134	CcSEcCtD
Carbamazepine—Protriptyline—ABCB1—melanoma	0.000261	0.0912	CrCbGaD
Carbamazepine—Nervous system disorder—Temozolomide—melanoma	0.000259	0.00133	CcSEcCtD
Carbamazepine—Thrombocytopenia—Temozolomide—melanoma	0.000259	0.00133	CcSEcCtD
Carbamazepine—Feeling abnormal—Bleomycin—melanoma	0.000258	0.00132	CcSEcCtD
Carbamazepine—Agranulocytosis—Docetaxel—melanoma	0.000257	0.00132	CcSEcCtD
Carbamazepine—Skin disorder—Temozolomide—melanoma	0.000257	0.00132	CcSEcCtD
Carbamazepine—Hypotension—Carmustine—melanoma	0.000256	0.00131	CcSEcCtD
Carbamazepine—Hyperhidrosis—Temozolomide—melanoma	0.000256	0.00131	CcSEcCtD
Carbamazepine—Decreased appetite—Dactinomycin—melanoma	0.000254	0.0013	CcSEcCtD
Carbamazepine—Fatigue—Dactinomycin—melanoma	0.000252	0.00129	CcSEcCtD
Carbamazepine—Anorexia—Temozolomide—melanoma	0.000252	0.00129	CcSEcCtD
Carbamazepine—Pain—Dactinomycin—melanoma	0.00025	0.00128	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Carmustine—melanoma	0.000249	0.00128	CcSEcCtD
Carbamazepine—Urticaria—Bleomycin—melanoma	0.000249	0.00128	CcSEcCtD
Carbamazepine—Rhinitis—Docetaxel—melanoma	0.000248	0.00127	CcSEcCtD
Carbamazepine—Body temperature increased—Bleomycin—melanoma	0.000248	0.00127	CcSEcCtD
Carbamazepine—Hepatitis—Docetaxel—melanoma	0.000248	0.00127	CcSEcCtD
Carbamazepine—Insomnia—Carmustine—melanoma	0.000248	0.00127	CcSEcCtD
Carbamazepine—Paraesthesia—Carmustine—melanoma	0.000246	0.00126	CcSEcCtD
Carbamazepine—Pharyngitis—Docetaxel—melanoma	0.000246	0.00126	CcSEcCtD
Carbamazepine—Urinary tract disorder—Docetaxel—melanoma	0.000244	0.00125	CcSEcCtD
Carbamazepine—Dyspnoea—Carmustine—melanoma	0.000244	0.00125	CcSEcCtD
Carbamazepine—Oedema peripheral—Docetaxel—melanoma	0.000244	0.00125	CcSEcCtD
Carbamazepine—Somnolence—Carmustine—melanoma	0.000243	0.00125	CcSEcCtD
Carbamazepine—Connective tissue disorder—Docetaxel—melanoma	0.000243	0.00125	CcSEcCtD
Carbamazepine—Urethral disorder—Docetaxel—melanoma	0.000243	0.00124	CcSEcCtD
Carbamazepine—Feeling abnormal—Dactinomycin—melanoma	0.000241	0.00123	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000241	0.00123	CcSEcCtD
Carbamazepine—Insomnia—Temozolomide—melanoma	0.000239	0.00123	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Dactinomycin—melanoma	0.000239	0.00122	CcSEcCtD
Carbamazepine—Decreased appetite—Carmustine—melanoma	0.000238	0.00122	CcSEcCtD
Carbamazepine—Paraesthesia—Temozolomide—melanoma	0.000238	0.00122	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Carmustine—melanoma	0.000236	0.00121	CcSEcCtD
Carbamazepine—Dyspnoea—Temozolomide—melanoma	0.000236	0.00121	CcSEcCtD
Carbamazepine—Somnolence—Temozolomide—melanoma	0.000235	0.0012	CcSEcCtD
Carbamazepine—Erythema multiforme—Docetaxel—melanoma	0.000234	0.0012	CcSEcCtD
Carbamazepine—Pain—Carmustine—melanoma	0.000234	0.0012	CcSEcCtD
Carbamazepine—Constipation—Carmustine—melanoma	0.000234	0.0012	CcSEcCtD
Carbamazepine—Dyspepsia—Temozolomide—melanoma	0.000233	0.00119	CcSEcCtD
Carbamazepine—Eye disorder—Docetaxel—melanoma	0.000231	0.00119	CcSEcCtD
Carbamazepine—Abdominal pain—Dactinomycin—melanoma	0.000231	0.00118	CcSEcCtD
Carbamazepine—Body temperature increased—Dactinomycin—melanoma	0.000231	0.00118	CcSEcCtD
Carbamazepine—Hypersensitivity—Bleomycin—melanoma	0.000231	0.00118	CcSEcCtD
Carbamazepine—Decreased appetite—Temozolomide—melanoma	0.00023	0.00118	CcSEcCtD
Carbamazepine—Flushing—Docetaxel—melanoma	0.00023	0.00118	CcSEcCtD
Carbamazepine—Cardiac disorder—Docetaxel—melanoma	0.00023	0.00118	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Temozolomide—melanoma	0.000228	0.00117	CcSEcCtD
Carbamazepine—Fatigue—Temozolomide—melanoma	0.000228	0.00117	CcSEcCtD
Carbamazepine—Pain—Temozolomide—melanoma	0.000226	0.00116	CcSEcCtD
Carbamazepine—Constipation—Temozolomide—melanoma	0.000226	0.00116	CcSEcCtD
Carbamazepine—Feeling abnormal—Carmustine—melanoma	0.000226	0.00116	CcSEcCtD
Carbamazepine—Asthenia—Bleomycin—melanoma	0.000225	0.00115	CcSEcCtD
Carbamazepine—Angiopathy—Docetaxel—melanoma	0.000225	0.00115	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Carmustine—melanoma	0.000224	0.00115	CcSEcCtD
Carbamazepine—Immune system disorder—Docetaxel—melanoma	0.000224	0.00115	CcSEcCtD
Carbamazepine—Mediastinal disorder—Docetaxel—melanoma	0.000223	0.00114	CcSEcCtD
Carbamazepine—Chills—Docetaxel—melanoma	0.000222	0.00114	CcSEcCtD
Carbamazepine—Pruritus—Bleomycin—melanoma	0.000222	0.00114	CcSEcCtD
Carbamazepine—Arrhythmia—Docetaxel—melanoma	0.000221	0.00113	CcSEcCtD
Carbamazepine—Alopecia—Docetaxel—melanoma	0.000219	0.00112	CcSEcCtD
Carbamazepine—Feeling abnormal—Temozolomide—melanoma	0.000218	0.00112	CcSEcCtD
Carbamazepine—Mental disorder—Docetaxel—melanoma	0.000217	0.00111	CcSEcCtD
Carbamazepine—Body temperature increased—Carmustine—melanoma	0.000216	0.00111	CcSEcCtD
Carbamazepine—Abdominal pain—Carmustine—melanoma	0.000216	0.00111	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Temozolomide—melanoma	0.000216	0.00111	CcSEcCtD
Carbamazepine—Erythema—Docetaxel—melanoma	0.000216	0.0011	CcSEcCtD
Carbamazepine—Malnutrition—Docetaxel—melanoma	0.000216	0.0011	CcSEcCtD
Carbamazepine—Hypersensitivity—Dactinomycin—melanoma	0.000215	0.0011	CcSEcCtD
Carbamazepine—Dysgeusia—Docetaxel—melanoma	0.000211	0.00108	CcSEcCtD
Carbamazepine—Urticaria—Temozolomide—melanoma	0.00021	0.00108	CcSEcCtD
Carbamazepine—Asthenia—Dactinomycin—melanoma	0.00021	0.00107	CcSEcCtD
Carbamazepine—Body temperature increased—Temozolomide—melanoma	0.000209	0.00107	CcSEcCtD
Carbamazepine—Abdominal pain—Temozolomide—melanoma	0.000209	0.00107	CcSEcCtD
Carbamazepine—Back pain—Docetaxel—melanoma	0.000208	0.00107	CcSEcCtD
Carbamazepine—Muscle spasms—Docetaxel—melanoma	0.000207	0.00106	CcSEcCtD
Carbamazepine—Hypersensitivity—Carmustine—melanoma	0.000202	0.00103	CcSEcCtD
Carbamazepine—Diarrhoea—Dactinomycin—melanoma	0.0002	0.00102	CcSEcCtD
Carbamazepine—Vomiting—Bleomycin—melanoma	0.000199	0.00102	CcSEcCtD
Carbamazepine—Anaemia—Docetaxel—melanoma	0.000199	0.00102	CcSEcCtD
Carbamazepine—Rash—Bleomycin—melanoma	0.000198	0.00101	CcSEcCtD
Carbamazepine—Dermatitis—Bleomycin—melanoma	0.000198	0.00101	CcSEcCtD
Carbamazepine—Asthenia—Carmustine—melanoma	0.000196	0.00101	CcSEcCtD
Carbamazepine—Hypersensitivity—Temozolomide—melanoma	0.000195	0.000998	CcSEcCtD
Carbamazepine—Syncope—Docetaxel—melanoma	0.000193	0.00099	CcSEcCtD
Carbamazepine—Epinastine—ABCB1—melanoma	0.000193	0.0676	CrCbGaD
Carbamazepine—Leukopenia—Docetaxel—melanoma	0.000193	0.000988	CcSEcCtD
Carbamazepine—Asthenia—Temozolomide—melanoma	0.00019	0.000972	CcSEcCtD
Carbamazepine—Loss of consciousness—Docetaxel—melanoma	0.000189	0.00097	CcSEcCtD
Carbamazepine—Diarrhoea—Carmustine—melanoma	0.000187	0.000959	CcSEcCtD
Carbamazepine—Pruritus—Temozolomide—melanoma	0.000187	0.000959	CcSEcCtD
Carbamazepine—Convulsion—Docetaxel—melanoma	0.000187	0.000956	CcSEcCtD
Carbamazepine—Oxcarbazepine—ALB—melanoma	0.000186	0.0653	CrCbGaD
Carbamazepine—Nausea—Bleomycin—melanoma	0.000186	0.000954	CcSEcCtD
Carbamazepine—Hypertension—Docetaxel—melanoma	0.000186	0.000953	CcSEcCtD
Carbamazepine—Vomiting—Dactinomycin—melanoma	0.000186	0.000952	CcSEcCtD
Carbamazepine—Rash—Dactinomycin—melanoma	0.000184	0.000944	CcSEcCtD
Carbamazepine—Myalgia—Docetaxel—melanoma	0.000183	0.00094	CcSEcCtD
Carbamazepine—Chest pain—Docetaxel—melanoma	0.000183	0.00094	CcSEcCtD
Carbamazepine—Arthralgia—Docetaxel—melanoma	0.000183	0.00094	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000182	0.000933	CcSEcCtD
Carbamazepine—Dizziness—Carmustine—melanoma	0.000181	0.000927	CcSEcCtD
Carbamazepine—Diarrhoea—Temozolomide—melanoma	0.000181	0.000927	CcSEcCtD
Carbamazepine—Dry mouth—Docetaxel—melanoma	0.000179	0.000919	CcSEcCtD
Carbamazepine—Confusional state—Docetaxel—melanoma	0.000177	0.000908	CcSEcCtD
Carbamazepine—Anaphylactic shock—Docetaxel—melanoma	0.000176	0.000901	CcSEcCtD
Carbamazepine—Oedema—Docetaxel—melanoma	0.000176	0.000901	CcSEcCtD
Carbamazepine—Dizziness—Temozolomide—melanoma	0.000175	0.000896	CcSEcCtD
Carbamazepine—Infection—Docetaxel—melanoma	0.000175	0.000895	CcSEcCtD
Carbamazepine—Vomiting—Carmustine—melanoma	0.000174	0.000891	CcSEcCtD
Carbamazepine—Nausea—Dactinomycin—melanoma	0.000174	0.00089	CcSEcCtD
Carbamazepine—Shock—Docetaxel—melanoma	0.000173	0.000886	CcSEcCtD
Carbamazepine—Rash—Carmustine—melanoma	0.000173	0.000884	CcSEcCtD
Carbamazepine—Nervous system disorder—Docetaxel—melanoma	0.000172	0.000884	CcSEcCtD
Carbamazepine—Dermatitis—Carmustine—melanoma	0.000172	0.000883	CcSEcCtD
Carbamazepine—Thrombocytopenia—Docetaxel—melanoma	0.000172	0.000882	CcSEcCtD
Carbamazepine—Tachycardia—Docetaxel—melanoma	0.000172	0.000879	CcSEcCtD
Carbamazepine—Headache—Carmustine—melanoma	0.000171	0.000878	CcSEcCtD
Carbamazepine—Skin disorder—Docetaxel—melanoma	0.000171	0.000875	CcSEcCtD
Carbamazepine—Vomiting—Temozolomide—melanoma	0.000168	0.000861	CcSEcCtD
Carbamazepine—Anorexia—Docetaxel—melanoma	0.000168	0.000859	CcSEcCtD
Carbamazepine—Rash—Temozolomide—melanoma	0.000167	0.000854	CcSEcCtD
Carbamazepine—Dermatitis—Temozolomide—melanoma	0.000167	0.000853	CcSEcCtD
Carbamazepine—Headache—Temozolomide—melanoma	0.000166	0.000849	CcSEcCtD
Carbamazepine—Hypotension—Docetaxel—melanoma	0.000164	0.000842	CcSEcCtD
Carbamazepine—Nausea—Carmustine—melanoma	0.000163	0.000833	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00016	0.000821	CcSEcCtD
Carbamazepine—Insomnia—Docetaxel—melanoma	0.000159	0.000815	CcSEcCtD
Carbamazepine—Paraesthesia—Docetaxel—melanoma	0.000158	0.000809	CcSEcCtD
Carbamazepine—Nausea—Temozolomide—melanoma	0.000157	0.000805	CcSEcCtD
Carbamazepine—Dyspnoea—Docetaxel—melanoma	0.000157	0.000803	CcSEcCtD
Carbamazepine—Somnolence—Docetaxel—melanoma	0.000156	0.000801	CcSEcCtD
Carbamazepine—Dyspepsia—Docetaxel—melanoma	0.000155	0.000793	CcSEcCtD
Carbamazepine—Decreased appetite—Docetaxel—melanoma	0.000153	0.000783	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Docetaxel—melanoma	0.000152	0.000778	CcSEcCtD
Carbamazepine—Fatigue—Docetaxel—melanoma	0.000152	0.000777	CcSEcCtD
Carbamazepine—Pain—Docetaxel—melanoma	0.00015	0.00077	CcSEcCtD
Carbamazepine—Constipation—Docetaxel—melanoma	0.00015	0.00077	CcSEcCtD
Carbamazepine—Feeling abnormal—Docetaxel—melanoma	0.000145	0.000742	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Docetaxel—melanoma	0.000144	0.000737	CcSEcCtD
Carbamazepine—Body temperature increased—Docetaxel—melanoma	0.000139	0.000712	CcSEcCtD
Carbamazepine—Abdominal pain—Docetaxel—melanoma	0.000139	0.000712	CcSEcCtD
Carbamazepine—Hypersensitivity—Docetaxel—melanoma	0.00013	0.000664	CcSEcCtD
Carbamazepine—Asthenia—Docetaxel—melanoma	0.000126	0.000646	CcSEcCtD
Carbamazepine—Pruritus—Docetaxel—melanoma	0.000124	0.000637	CcSEcCtD
Carbamazepine—Phenytoin—ALB—melanoma	0.000123	0.0432	CrCbGaD
Carbamazepine—Diarrhoea—Docetaxel—melanoma	0.00012	0.000616	CcSEcCtD
Carbamazepine—Phenytoin—ABCB1—melanoma	0.000118	0.0413	CrCbGaD
Carbamazepine—Dizziness—Docetaxel—melanoma	0.000116	0.000596	CcSEcCtD
Carbamazepine—Vomiting—Docetaxel—melanoma	0.000112	0.000573	CcSEcCtD
Carbamazepine—Rash—Docetaxel—melanoma	0.000111	0.000568	CcSEcCtD
Carbamazepine—Dermatitis—Docetaxel—melanoma	0.000111	0.000568	CcSEcCtD
Carbamazepine—Headache—Docetaxel—melanoma	0.00011	0.000564	CcSEcCtD
Carbamazepine—Nausea—Docetaxel—melanoma	0.000104	0.000535	CcSEcCtD
Carbamazepine—Trimipramine—ABCB1—melanoma	9.4e-05	0.0329	CrCbGaD
Carbamazepine—Promethazine—ABCB1—melanoma	9.05e-05	0.0317	CrCbGaD
Carbamazepine—Desipramine—ABCB1—melanoma	8.22e-05	0.0288	CrCbGaD
Carbamazepine—Imipramine—ABCB1—melanoma	6.97e-05	0.0244	CrCbGaD
Carbamazepine—SCN5A—Developmental Biology—AKT1—melanoma	1.41e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GPAM—melanoma	1.41e-05	0.000101	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.41e-05	0.0001	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.41e-05	0.0001	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PIK3CA—melanoma	1.4e-05	9.98e-05	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—melanoma	1.36e-05	9.65e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.34e-05	9.55e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—LUM—melanoma	1.34e-05	9.55e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PHGDH—melanoma	1.34e-05	9.55e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.33e-05	9.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—VCAN—melanoma	1.33e-05	9.44e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP17A1—melanoma	1.32e-05	9.41e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PLA2G6—melanoma	1.32e-05	9.38e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HPSE—melanoma	1.32e-05	9.36e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CG—melanoma	1.31e-05	9.3e-05	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—melanoma	1.3e-05	9.23e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP17A1—melanoma	1.29e-05	9.19e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CUBN—melanoma	1.29e-05	9.19e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PLA2G6—melanoma	1.29e-05	9.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLCB4—melanoma	1.27e-05	9.04e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PPARG—melanoma	1.26e-05	8.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.26e-05	8.94e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNA11—melanoma	1.25e-05	8.88e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CSPG4—melanoma	1.25e-05	8.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SDHD—melanoma	1.25e-05	8.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BSG—melanoma	1.25e-05	8.87e-05	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—IL6—melanoma	1.24e-05	8.83e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ABCB1—melanoma	1.24e-05	8.82e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.22e-05	8.71e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—FASN—melanoma	1.22e-05	8.69e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNA11—melanoma	1.22e-05	8.68e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.21e-05	8.62e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GPAM—melanoma	1.21e-05	8.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PLA2G6—melanoma	1.2e-05	8.55e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SLC5A5—melanoma	1.2e-05	8.55e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.19e-05	8.5e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC6A11—melanoma	1.19e-05	8.5e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—FASN—melanoma	1.19e-05	8.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—VCAN—melanoma	1.18e-05	8.43e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.18e-05	8.42e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SLC5A5—melanoma	1.17e-05	8.36e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTAP—melanoma	1.16e-05	8.27e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNAQ—melanoma	1.16e-05	8.26e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CD44—melanoma	1.16e-05	8.26e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—VCAN—melanoma	1.16e-05	8.22e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CD—melanoma	1.15e-05	8.18e-05	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—melanoma	1.15e-05	8.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PRKCA—melanoma	1.14e-05	8.11e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNAQ—melanoma	1.13e-05	8.07e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CD44—melanoma	1.13e-05	8.07e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ALB—melanoma	1.13e-05	8.07e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ERCC2—melanoma	1.13e-05	8.05e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.12e-05	7.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP17A1—melanoma	1.12e-05	7.96e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP1B1—melanoma	1.11e-05	7.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.1e-05	7.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.09e-05	7.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP1B1—melanoma	1.09e-05	7.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.08e-05	7.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—VCAN—melanoma	1.08e-05	7.68e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNA11—melanoma	1.06e-05	7.52e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PHGDH—melanoma	1.04e-05	7.37e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—LUM—melanoma	1.04e-05	7.37e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—FASN—melanoma	1.03e-05	7.36e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PLA2G6—melanoma	1.03e-05	7.31e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.02e-05	7.27e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SLC5A5—melanoma	1.02e-05	7.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HPSE—melanoma	1.02e-05	7.23e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CB—melanoma	1e-05	7.13e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1e-05	7.11e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP17A1—melanoma	9.99e-06	7.11e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CUBN—melanoma	9.97e-06	7.09e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—melanoma	9.92e-06	7.06e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.86e-06	7.02e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.85e-06	7.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNAQ—melanoma	9.82e-06	6.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CD44—melanoma	9.82e-06	6.99e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP17A1—melanoma	9.75e-06	6.94e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	9.73e-06	6.92e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SDHD—melanoma	9.62e-06	6.85e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CSPG4—melanoma	9.62e-06	6.85e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BSG—melanoma	9.62e-06	6.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.62e-06	6.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.53e-06	6.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNA11—melanoma	9.43e-06	6.71e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP1B1—melanoma	9.42e-06	6.7e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GPAM—melanoma	9.32e-06	6.63e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—FASN—melanoma	9.23e-06	6.57e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—VCAN—melanoma	9.22e-06	6.56e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNA11—melanoma	9.21e-06	6.55e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—melanoma	9.16e-06	6.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP17A1—melanoma	9.11e-06	6.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SLC5A5—melanoma	9.08e-06	6.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.03e-06	6.42e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—FASN—melanoma	9.01e-06	6.41e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.98e-06	6.39e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—melanoma	8.96e-06	6.37e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—melanoma	8.93e-06	6.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	8.87e-06	6.31e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SLC5A5—melanoma	8.86e-06	6.31e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNAQ—melanoma	8.77e-06	6.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CD44—melanoma	8.77e-06	6.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.73e-06	6.21e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—melanoma	8.65e-06	6.16e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PPARG—melanoma	8.62e-06	6.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNA11—melanoma	8.6e-06	6.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.59e-06	6.11e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNAQ—melanoma	8.56e-06	6.09e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CD44—melanoma	8.56e-06	6.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.51e-06	6.06e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PRKCA—melanoma	8.43e-06	6e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.43e-06	6e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—FASN—melanoma	8.42e-06	5.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP1B1—melanoma	8.41e-06	5.98e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ERCC2—melanoma	8.36e-06	5.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.31e-06	5.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SLC5A5—melanoma	8.28e-06	5.89e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PRKCA—melanoma	8.24e-06	5.87e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP1B1—melanoma	8.21e-06	5.84e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ERCC2—melanoma	8.17e-06	5.82e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNAQ—melanoma	8e-06	5.69e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CD44—melanoma	8e-06	5.69e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLA2G6—melanoma	7.93e-06	5.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CD—melanoma	7.85e-06	5.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.83e-06	5.57e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP17A1—melanoma	7.78e-06	5.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.76e-06	5.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—melanoma	7.76e-06	5.52e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ALB—melanoma	7.75e-06	5.52e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.68e-06	5.46e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP1B1—melanoma	7.67e-06	5.46e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	7.58e-06	5.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.42e-06	5.28e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNA11—melanoma	7.35e-06	5.23e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—FASN—melanoma	7.19e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PRKCA—melanoma	7.14e-06	5.08e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—VCAN—melanoma	7.12e-06	5.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ERCC2—melanoma	7.08e-06	5.04e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC5A5—melanoma	7.07e-06	5.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—melanoma	6.92e-06	4.93e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CB—melanoma	6.84e-06	4.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CD44—melanoma	6.83e-06	4.86e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNAQ—melanoma	6.83e-06	4.86e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—melanoma	6.78e-06	4.83e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.77e-06	4.81e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.69e-06	4.76e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.63e-06	4.72e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—melanoma	6.6e-06	4.7e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP1B1—melanoma	6.55e-06	4.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—melanoma	6.46e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPARG—melanoma	6.37e-06	4.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PRKCA—melanoma	6.37e-06	4.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ERCC2—melanoma	6.32e-06	4.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—melanoma	6.31e-06	4.49e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PPARG—melanoma	6.23e-06	4.43e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PRKCA—melanoma	6.22e-06	4.43e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ERCC2—melanoma	6.17e-06	4.39e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—melanoma	6.1e-06	4.34e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP17A1—melanoma	6.01e-06	4.27e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—melanoma	5.91e-06	4.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.86e-06	4.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PRKCA—melanoma	5.81e-06	4.13e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CD—melanoma	5.81e-06	4.13e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.78e-06	4.11e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ERCC2—melanoma	5.76e-06	4.1e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALB—melanoma	5.73e-06	4.08e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CD—melanoma	5.67e-06	4.04e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNA11—melanoma	5.67e-06	4.04e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALB—melanoma	5.6e-06	3.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—melanoma	5.59e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—FASN—melanoma	5.55e-06	3.95e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC5A5—melanoma	5.46e-06	3.89e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PPARG—melanoma	5.4e-06	3.84e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—melanoma	5.39e-06	3.84e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CD44—melanoma	5.27e-06	3.75e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNAQ—melanoma	5.27e-06	3.75e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.23e-06	3.73e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CB—melanoma	5.06e-06	3.6e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP1B1—melanoma	5.06e-06	3.6e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—melanoma	5.01e-06	3.57e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—melanoma	4.99e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—melanoma	4.99e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PRKCA—melanoma	4.96e-06	3.53e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CB—melanoma	4.95e-06	3.52e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ERCC2—melanoma	4.92e-06	3.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CD—melanoma	4.92e-06	3.5e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—melanoma	4.9e-06	3.49e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—melanoma	4.87e-06	3.47e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALB—melanoma	4.85e-06	3.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPARG—melanoma	4.82e-06	3.43e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.77e-06	3.4e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPARG—melanoma	4.7e-06	3.35e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—melanoma	4.55e-06	3.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPARG—melanoma	4.39e-06	3.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CD—melanoma	4.39e-06	3.12e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—melanoma	4.37e-06	3.11e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALB—melanoma	4.33e-06	3.08e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CB—melanoma	4.28e-06	3.05e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CD—melanoma	4.28e-06	3.05e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—melanoma	4.27e-06	3.04e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—melanoma	4.25e-06	3.02e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALB—melanoma	4.23e-06	3.01e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—melanoma	4.17e-06	2.97e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—melanoma	4.16e-06	2.96e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.08e-06	2.9e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CD—melanoma	4e-06	2.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALB—melanoma	3.95e-06	2.81e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—melanoma	3.89e-06	2.77e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PRKCA—melanoma	3.83e-06	2.73e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CB—melanoma	3.82e-06	2.72e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ERCC2—melanoma	3.8e-06	2.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—melanoma	3.79e-06	2.7e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPARG—melanoma	3.75e-06	2.67e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CB—melanoma	3.73e-06	2.66e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—melanoma	3.7e-06	2.63e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—melanoma	3.7e-06	2.63e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CB—melanoma	3.49e-06	2.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—melanoma	3.46e-06	2.46e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CD—melanoma	3.42e-06	2.43e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—melanoma	3.41e-06	2.43e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALB—melanoma	3.37e-06	2.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—melanoma	3.3e-06	2.35e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—melanoma	3.23e-06	2.3e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—melanoma	3.09e-06	2.2e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—melanoma	3.02e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—melanoma	3.01e-06	2.14e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—melanoma	3e-06	2.14e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CB—melanoma	2.98e-06	2.12e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—melanoma	2.95e-06	2.1e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPARG—melanoma	2.9e-06	2.06e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CD—melanoma	2.64e-06	1.88e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—melanoma	2.61e-06	1.86e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALB—melanoma	2.6e-06	1.85e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—melanoma	2.57e-06	1.83e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—melanoma	2.52e-06	1.79e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—melanoma	2.46e-06	1.75e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—melanoma	2.33e-06	1.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CB—melanoma	2.3e-06	1.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—melanoma	2.28e-06	1.62e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—melanoma	2.28e-06	1.62e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—melanoma	2.13e-06	1.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—melanoma	2.13e-06	1.51e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—melanoma	1.99e-06	1.41e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—melanoma	1.9e-06	1.36e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—melanoma	1.86e-06	1.32e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—melanoma	1.82e-06	1.29e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—melanoma	1.74e-06	1.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—melanoma	1.48e-06	1.06e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—melanoma	1.4e-06	9.98e-06	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—melanoma	1.15e-06	8.15e-06	CbGpPWpGaD
